[ Back to EurekAlert! ]

Contact: Sarah Avery
Duke University Medical Center


Caption: Engineered to specifically link with the body’s immune fighters (T-cells) on one side, and a cancer cell on the other, the bispecific T-cell engager (BiTE) serves as a connector that tethers cancer to its killer.

Credit: Duke Medicine

Usage Restrictions: None

Related news release: Duke Medicine News new immune therapy successfully treats brain tumors in mice

[ Back to EurekAlert! ]